Search
Searching Content indexed under Food, Drugs, Healthcare, Life Sciences by Kristina Caggiano Kelly ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Addressing Breach Of Method-Of-Use Patents By Generics
The U.S. Court of Appeals for the Federal Circuit on April 16, 2012, in "Bayer Schering Pharma AG v. Sandoz Inc.", Nos. 2011-1143, -1228 (Yasmin), affirmed a district court's holding that as a matter of law, generic drug makers could not infringe patent claims reciting a method of use of a U.S. Food and Drug Administration (FDA)-approved drug where the FDA had not approved the drug for the claimed uses, and where the FDA-approved labeling did not indicate instructions or intent to encourage the
United States
10 May 2012
2
Federal Circuit Addresses Infringement Of Method-Of-Use Patents By Generics In Yasmin® Case
The U.S. Court of Appeals for the Federal Circuit on April 16, 2012, in "Bayer Schering Pharma AG v. Sandoz, Inc.", Nos. 2011-1143, -1228 (YASMIN®), affirmed a district court's holding that as a matter of law, generic drug makers could not infringe patent claims reciting a method of use of an FDA-approved drug where the U.S. Food and Drug Administration had not approved the drug for the claimed uses, and where the FDA-approved labeling did not indicate instructions or intent to encourage the cla
United States
24 Apr 2012
Links to Result pages
 
1